Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H
Servicio de ORL, Hospital Clínic, Barcelona.
Acta Otorrinolaringol Esp. 2000 May;51(4):299-307.
Cholesteatomas of the middle ear are frequently aggressive and produce bone destruction. Stimulation of the surrounding inflammatory tissue and autocrine mechanisms could be responsible for the keratinocytic dysregulation of cholesteatomas, as well as for abnormal proliferation patterns. The proliferative capacity of human cholesteatoma of the middle ear was studied through the kinetics of the epithelial cells of cholesteatomas and external ear canal. The APAAP method was used to study the monoclonal antibody MIB-1, which recognizes an antigen of cells in the division phase. Biopsies taken from the outer ear canal (n = 7) revealed an MIB-1 level (the ratio of MIB-1 positive cells to all cells) of 7.6% +/- 2.2%. Cholesteatoma samples (n = 13) showed an MIB-1 level of 17.4% +/- 8.9%, and heterogeneity of the proliferative areas. Epithelial invaginations into the surrounding stroma were characterized by intense mitotic activity. The results confirmed a statistically significant increase in keratinocytes in the cholesteatomas, with an MIB-1 level 2.3 times higher than that of meatal keratinocytes. PCNA, a nuclear proliferation antigen which expresses the growth phase of cells in normal and tumoral tissue, was determined in 15 biopsies of meatal skin and 7 specimens of cholesteatoma in the phase of infection and 8 non-infection. Although the number of proliferative cells changed depending on the site of the cholesteatorna, the amount of PCNA-positive cells was significantly higher in the cholesteatoma (2.5-15, mean 9.3) than in normal skin (1-2.8, mean 1.5) (p < 0.001). Finally, AgNOR (argyrophyllic nucleolar organizer regions), which express proliferative activity, were determined in 12 specimens of meatal skin and in 19 acquired and 2 congenital cholesteatomas. A mean of 3.71 AgNOR dots were counted in the cholesteatomas and 1.54 dots in meatal skin specimens. The immunohistological study with three different markers expressing cellular proliferative capacity showed hyperproliferation associated with keratinocyte dysregulation in cholesteatoma samples, which could explain the clinically aggressive and destructive behavior of these lesions.
中耳胆脂瘤通常具有侵袭性并会导致骨质破坏。刺激周围炎症组织和自分泌机制可能是胆脂瘤角质形成细胞失调以及异常增殖模式的原因。通过中耳胆脂瘤和外耳道上皮细胞的动力学研究了人中耳胆脂瘤的增殖能力。采用抗碱性磷酸酶桥联酶标法(APAAP法)研究识别分裂期细胞抗原的单克隆抗体MIB-1。取自外耳道的活检标本(n = 7)显示MIB-1水平(MIB-1阳性细胞与所有细胞的比例)为7.6%±2.2%。胆脂瘤样本(n = 13)显示MIB-1水平为17.4%±8.9%,且增殖区域存在异质性。上皮向周围基质的内陷以强烈的有丝分裂活性为特征。结果证实胆脂瘤中的角质形成细胞有统计学意义的增加,MIB-1水平比耳道角质形成细胞高2.3倍。增殖细胞核抗原(PCNA)是一种在正常组织和肿瘤组织中表达细胞生长阶段的核增殖抗原,在15例耳道皮肤活检标本以及7例处于感染期和8例非感染期的胆脂瘤标本中进行了检测。尽管增殖细胞的数量因胆脂瘤的部位而异,但胆脂瘤中PCNA阳性细胞的数量(2.5 - 15,平均9.3)显著高于正常皮肤(1 - 2.8,平均1.5)(p < 0.001)。最后,在12例耳道皮肤标本以及19例后天性和2例先天性胆脂瘤中检测了表达增殖活性的嗜银核仁组成区(AgNOR)。胆脂瘤中平均计数到3.71个AgNOR点,耳道皮肤标本中为1.54个点。用三种表达细胞增殖能力的不同标志物进行的免疫组织学研究显示,胆脂瘤样本中存在与角质形成细胞失调相关的过度增殖,这可以解释这些病变临床上的侵袭性和破坏性表现。